T1	Entity 46 51	XRCC6
T2	Entity 22 30	promoter
T3	SNP 2 14	polymorphism
T4	Association 53 63	associated
E1	Association:T4 snp_int:T3 bc:T5
T5	Cancer 69 82	breast cancer
R1	SNP_location Arg1:T3 Arg2:T2	
R2	SNP_coupled_gene Arg1:T3 Arg2:T1	
T7	Organic_inorganic_molecules_affected 41 45	Ku70
E3	Organic_inorganic_molecules_affected:T7 Agent:T3
T8	SNP 113 126	Polymorphisms
T9	Entity 130 162	double strand break repair genes
R3	SNP_coupled_gene Arg1:T8 Arg2:T9	
T10	Spec 163 171	could be
T11	Association 184 191;206 220	genetic predisposition
E4	Association:T11 snp_int:T8
T12	Cancer 192 205	breast cancer
R4	Speculation_marker Arg1:E4 Arg2:T10	
T13	Effect_Type 224 232	enhanced
T14	Organic_inorganic_molecules_affected 245 261	radiosensitivity
E5	Organic_inorganic_molecules_affected:T14 Theme:T15 Agent:T8
T15	Entity 233 244	chromosomal
R5	Effect_type_marker Arg1:E5 Arg2:T13	
A1	Effect_Type E5 Increase
R6	Speculation_marker Arg1:E5 Arg2:T10	
T16	SNP 311 322	c.-1310 C>G
T17	Entity 313 318	-1310
T18	Entity 319 322	C>G
R7	SNP_location Arg1:T16 Arg2:T17	
R8	Nucleotide_substitution Arg1:T16 Arg2:T18	
T19	Entity 348 356	promoter
R9	SNP_location Arg1:T16 Arg2:T19	
T20	Organic_inorganic_molecules_affected 343 347	Ku70
E6	Organic_inorganic_molecules_affected:T20 Agent:T16
R10	SNP_coupled_gene Arg1:T16 Arg2:T1	
T21	Level 367 378	significant
T22	Association 379 389	odds ratio
E7	Association:T22 snp_int:T16
A2	Level E7 High
T23	Cancer 418 426;445 458	sporadic breast cancer
A3	Cancer_Type T23 Non_hereditary
T24	Neg 432 435	not
T25	Cancer 436 458	familial breast cancer
A4	Cancer_Type T25 Familial
E8	Association:T22 bc:T25 snp_int:T16
R11	Negation_marker Arg1:E8 Arg2:T24	
T27	Level 923 927	high
T28	Level 932 943	significant
T29	Association 944 947	ORs
E9	Association:T29 bc:T36 snp_int:T41
A5	Level E9 High
R12	Level_marker Arg1:E9 Arg2:T28	
R13	Level_marker Arg1:E9 Arg2:T27	
T30	SNP 1097 1108	c.-1310 C>G
T31	Entity 1079 1093	variant allele
R14	SNP_allele Arg1:T30 Arg2:T31	
T32	Entity 1130 1138	promoter
T34	Organic_inorganic_molecules_affected 1125 1129	Ku70
E10	Organic_inorganic_molecules_affected:T34 Agent:T30
R15	SNP_location Arg1:T30 Arg2:T32	
T33	Entity 1145 1156	risk allele
R16	Equiv Arg1:T31 Arg2:T33	
T35	Association 1145 1149	risk
E11	Association:T35 snp_int:T30 bc:T36
T36	Cancer 1161 1174	breast cancer
T37	Entity 1105 1108	C>G
R17	Nucleotide_substitution Arg1:T30 Arg2:T37	
T38	Entity 1099 1104	-1310
R18	SNP_location Arg1:T30 Arg2:T38	
R19	SNP_coupled_gene Arg1:T30 Arg2:T1	
R20	Equiv Arg1:T3 Arg2:T16	
T39	Entity 1268 1273	women
R21	Population_assignment Arg1:T30 Arg2:T39	
T40	Entity 832 839	Belgian
R22	Population_assignment Arg1:T30 Arg2:T40	
R23	Population_assignment Arg1:T3 Arg2:T40	
R24	Population_assignment Arg1:T3 Arg2:T39	
T41	SNP 1212 1223	c.-1310 C>G
T42	Level 1256 1264	stronger
T43	Association 1193 1204	association
E12	Association:T43 snp_int:T41 bc:T45
A6	Level E12 High
R26	Level_marker Arg1:E12 Arg2:T42	
T44	Entity 1281 1304	long oestrogen exposure
R27	Risk_Factor Arg1:T41 Arg2:T44	
T45	Cancer 1233 1246	breast cancer
T47	Entity 1005 1026	late age at menopause
R25	Risk_Factor Arg1:T41 Arg2:T47	
T46	Entity 1214 1219	-1310
T48	Entity 1220 1223	C>G
R28	SNP_location Arg1:T41 Arg2:T46	
R29	Nucleotide_substitution Arg1:T41 Arg2:T48	
R30	SNP_coupled_gene Arg1:T41 Arg2:T1	
